(Q64598059)
Statements
BEACON (English)
0 references
A Randomised Phase IIb Trial of Bevacizumab Added to Temozolomide ± Irinotecan for Children With Refractory/Relapsed Neuroblastoma - BEACON-Neuroblastoma Trial (English)
0 references
July 2013
0 references
September 2018
0 references
160
0 references
21 year
0 references